ZIVO insider trading
OTC Markets OTCQB HealthcareZivo Bioscience, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About Zivo Bioscience, Inc.
ZIVO Bioscience, Inc., together with its subsidiaries, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. It offers poultry gut health, avian influenza, bovine mastitis, canine joint health, human immune modification, human functional food ingredients, algal biomass for human food, and biomass for supporting skin health and anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Troy, Michigan.
Company website: www.zivobioscience.com
ZIVO insider activity at a glance
FilingIQ has scored 252 insider transactions for ZIVO since Sep 19, 2014. The most recent filing in our index is dated Apr 17, 2026.
Across the full history, 216 open-market purchases
and 1 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on ZIVO insider trades is 57.3/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest ZIVO Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for ZIVO?
- FilingIQ tracks 252 Form 4 insider transactions for ZIVO (Zivo Bioscience, Inc.), covering filings from Sep 19, 2014 onwards. 2 of those were filed in the last 90 days.
- Are ZIVO insiders net buyers or net sellers?
- Across the full Form 4 history for ZIVO, 216 transactions (86%) were open-market purchases and 1 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does ZIVO insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is ZIVO in?
- Zivo Bioscience, Inc. (ZIVO) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $36.94M.
Methodology & sources
Every ZIVO insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.